Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #: NBSB19001DA3, Exp. date 02/2021
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- AuroMedics Pharma LLC
- Reason for Recall:
- CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- ongoing
Product Information
Full Description:
Ranitidine Tablets USP,150 mg, 8-count bottles, Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79
Product Codes/Lot Numbers:
Lot #: NBSB19001DA3, Exp. date 02/2021
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0166-2020
Related Recalls
Class I - Dangerous
Subpotent Drug: Out of specification for assay
Class I - Dangerous
Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.
Class I - Dangerous
Presence of Particulate Matter: Piece of metal found in a vial